Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

Hussein Chalhoub; Michael Tunney; J. Stuart Elborn; Anne Vergison; Olivier Denis; Patrick Plésiat; Barbara C. Kahl; Françoise Van Bambeke; Paul M. Tulkens

doi:10.1093/jac/dku551

Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

Hussein Chalhoub, Michael Tunney, J. Stuart Elborn, Anne Vergison, Olivier Denis, Patrick Plésiat, Barbara C. Kahl, Françoise Van Bambeke, Paul M. Tulkens^*

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

25 Citations (Scopus)

Original language	English
Article number	dku551
Pages (from-to)	1596-1598
Number of pages	3
Journal	Journal of Antimicrobial Chemotherapy
Volume	70
Issue number	5
Early online date	14 Jan 2015
DOIs	https://doi.org/10.1093/jac/dku551
Publication status	Published - May 2015

Keywords

Carbapenemases
Esbls
Extended-spectrum β-lactamases
P. aeruginosa
β-lactamase inhibition

ASJC Scopus subject areas

Pharmacology
Microbiology (medical)
Infectious Diseases
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/jac/dku551

Cite this

Chalhoub, H., Tunney, M., Stuart Elborn, J., Vergison, A., Denis, O., Plésiat, P., Kahl, B. C., Van Bambeke, F., & Tulkens, P. M. (2015). Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. Journal of Antimicrobial Chemotherapy, 70(5), 1596-1598. [dku551]. https://doi.org/10.1093/jac/dku551

Chalhoub, Hussein ; Tunney, Michael ; Stuart Elborn, J. ; Vergison, Anne ; Denis, Olivier ; Plésiat, Patrick ; Kahl, Barbara C. ; Van Bambeke, Françoise ; Tulkens, Paul M. / Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. In: Journal of Antimicrobial Chemotherapy. 2015 ; Vol. 70, No. 5. pp. 1596-1598.

@article{42576fe90a46455d9b4b84b014c80838,

title = "Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients",

keywords = "Carbapenemases, Esbls, Extended-spectrum β-lactamases, P. aeruginosa, β-lactamase inhibition",

author = "Hussein Chalhoub and Michael Tunney and {Stuart Elborn}, J. and Anne Vergison and Olivier Denis and Patrick Pl{\'e}siat and Kahl, {Barbara C.} and {Van Bambeke}, Fran{\c c}oise and Tulkens, {Paul M.}",

year = "2015",

month = may,

doi = "10.1093/jac/dku551",

language = "English",

volume = "70",

pages = "1596--1598",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "5",

}

Chalhoub, H, Tunney, M, Stuart Elborn, J, Vergison, A, Denis, O, Plésiat, P, Kahl, BC, Van Bambeke, F & Tulkens, PM 2015, 'Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients', Journal of Antimicrobial Chemotherapy, vol. 70, no. 5, dku551, pp. 1596-1598. https://doi.org/10.1093/jac/dku551

Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients. / Chalhoub, Hussein; Tunney, Michael; Stuart Elborn, J.; Vergison, Anne; Denis, Olivier; Plésiat, Patrick; Kahl, Barbara C.; Van Bambeke, Françoise; Tulkens, Paul M.

In: Journal of Antimicrobial Chemotherapy, Vol. 70, No. 5, dku551, 05.2015, p. 1596-1598.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

AU - Chalhoub, Hussein

AU - Tunney, Michael

AU - Stuart Elborn, J.

AU - Vergison, Anne

AU - Denis, Olivier

AU - Plésiat, Patrick

AU - Kahl, Barbara C.

AU - Van Bambeke, Françoise

AU - Tulkens, Paul M.

PY - 2015/5

Y1 - 2015/5

KW - Carbapenemases

KW - Esbls

KW - Extended-spectrum β-lactamases

KW - P. aeruginosa

KW - β-lactamase inhibition

UR - http://www.scopus.com/inward/record.url?scp=84929761996&partnerID=8YFLogxK

U2 - 10.1093/jac/dku551

DO - 10.1093/jac/dku551

M3 - Letter

C2 - 25587996

AN - SCOPUS:84929761996

VL - 70

SP - 1596

EP - 1598

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 5

M1 - dku551

ER -

Avibactam confers susceptibility to a large proportion of ceftazidimeresistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this